0001553350-16-001825.txt : 20160401 0001553350-16-001825.hdr.sgml : 20160401 20160401113953 ACCESSION NUMBER: 0001553350-16-001825 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160330 FILED AS OF DATE: 20160401 DATE AS OF CHANGE: 20160401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apollo Medical Holdings, Inc. CENTRAL INDEX KEY: 0001083446 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742] IRS NUMBER: 870042699 STATE OF INCORPORATION: DE FISCAL YEAR END: 0131 BUSINESS ADDRESS: STREET 1: 450 NORTH BRAND BLVD., STREET 2: SUITE 600 CITY: GLENDALE STATE: CA ZIP: 91203 BUSINESS PHONE: 818-396-8050 MAIL ADDRESS: STREET 1: 700 NORTH BRAND BLVD., STREET 2: SUITE 1400 CITY: GLENDALE STATE: CA ZIP: 91203 FORMER COMPANY: FORMER CONFORMED NAME: SICLONE INDUSTRIES INC DATE OF NAME CHANGE: 19990413 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Network Medical Management, Inc. CENTRAL INDEX KEY: 0001656434 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37392 FILM NUMBER: 161545705 BUSINESS ADDRESS: STREET 1: 1668 S. GARFIELD AVE., 2ND FL. CITY: ALHAMBRA STATE: CA ZIP: 91801 BUSINESS PHONE: (626) 943-6238 MAIL ADDRESS: STREET 1: 1668 S. GARFIELD AVE., 2ND FL. CITY: ALHAMBRA STATE: CA ZIP: 91801 4 1 nmm4.xml OWNERSHIP DOCUMENT X0306 4 2016-03-30 0 0001083446 Apollo Medical Holdings, Inc. AMEH 0001656434 Network Medical Management, Inc. 1668 S. GARFIELD AVE. 2ND FL. ALHAMBRA CA 91801 0 0 1 0 Series B Preferred Stock 2016-03-30 4 P 0 555555 9.00 A 2016-03-30 Common Stock 555555 555555 D Warrants to purchase Common Stock 10.00 2016-03-30 4 P 0 555555 9.00 A 2016-03-30 2021-03-30 Common Stock 555555 1666666 D Reporting Party purchased 555,555 investment units at $9.00 per unit. Each investment unit is comprised of (a) one (1) share of Series B Preferred Stock that may be converted into one (1) share of Common Stock, and (b) one (1) warrant to purchase one (1) share of Common Stock at an exercise price of $10.00 per share. The Series B Preferred Stock is convertible into Common Stock, (a) at the option of the holder thereof at any time after issuance, and (b) mandatorily at any time prior to and including March 31, 2017, if the Issuer receives aggregate gross proceeds of not less than $5,000,000 in one or more transactions for the sale of its equity securities or securities convertible into, or exchangeable for, equity securities (other than any transactions with the holder of the Series B Preferred Stock). The Series B Preferred Stock is convertible into Common Stock at an initial conversion rate of one-for-one, subject to adjustment in the event of stock dividends, stock splits and certain other similar transactions. /s/ Thomas S. Lam, M.D. 2016-04-01